Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2007-08-21
2007-08-21
Chen, Shin-Lin (Department: 1632)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C424S093200, C435S320100, C435S455000, C536S023500
Reexamination Certificate
active
10623155
ABSTRACT:
Compositions and methods for the therapy and diagnosis of cancer, particularly lung cancer, are disclosed. Illustrative compositions comprise one or more lung tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly lung cancer.
REFERENCES:
patent: 5589579 (1996-12-01), Torczynski et al.
patent: 5705159 (1998-01-01), Irie et al.
patent: 5783422 (1998-07-01), Suminami et al.
patent: 6200764 (2001-03-01), Carney
patent: 6297364 (2001-10-01), Chen et al.
patent: 6309857 (2001-10-01), Pauli et al.
patent: 2002/0119463 (2002-08-01), Faris et al.
patent: 679716 (1994-11-01), None
patent: 695760 (1996-02-01), None
patent: 1033401 (2000-09-01), None
patent: 1130094 (2001-09-01), None
patent: WO91/18926 (1991-12-01), None
patent: WO94/06929 (1994-09-01), None
patent: WO95/21862 (1995-08-01), None
patent: WO96/02552 (1996-02-01), None
patent: WO 96/02552 (1996-02-01), None
patent: WO96/13610 (1996-05-01), None
patent: WO96/28473 (1996-09-01), None
patent: WO96/30389 (1996-10-01), None
patent: WO97/07244 (1997-02-01), None
patent: WO98/35985 (1998-08-01), None
patent: WO98/46788 (1998-10-01), None
patent: WO99/06550 (1999-02-01), None
patent: WO99/38973 (1999-08-01), None
patent: WO99/44620 (1999-09-01), None
patent: WO99/46594 (1999-09-01), None
patent: WO99/47674 (1999-09-01), None
patent: WO99/54738 (1999-10-01), None
patent: WO 00/12711 (2000-09-01), None
patent: WO 00/61612 (2000-10-01), None
patent: WO 01/47944 (2001-07-01), None
patent: WO 01/55322 (2001-08-01), None
patent: WO 01/57272 (2001-08-01), None
patent: WO 01/57275 (2001-08-01), None
patent: WO 01/57276 (2001-08-01), None
patent: WO 01/57277 (2001-08-01), None
patent: WO 01/75067 (2001-10-01), None
patent: WO 01/94629 (2001-12-01), None
patent: WO 02/000174 (2002-01-01), None
patent: WO 02/10449 (2002-02-01), None
patent: WO 02/14366 (2002-02-01), None
patent: WO 02/20036 (2002-03-01), None
Hillier et al., 1997, EST Accession No. AA429919, computer printout p. 17-18.
Hillier et al., 1998, EST Accession No. AA160879, computer printout p. 31.
Rudinger, 1976, Peptide Hormones, Parsons, University Park Press, Baltimore, p. 1-7.
Kaye et al., 1990, Proc. Natl. Acad. Sci. USA, vol. 87, pp. 6922-6926.
Skolnick et al., 2000, Trends in Biotech, vol. 18, p. 34-39.
Deonarain, 1998, Expert Opin. Ther. Pat., vol. 8, pp. 53-69.
Verma, Sep. 1997, Nature, vol. 389, pp. 239-242.
Crystal, 1995, Science, vol. 270, p. 404-410.
Eck et al., 1996, Goodman & Gilman's The Pharmacological Basis of Therapeutics, McGraw-Hill, New York, p. 77-101.
Ackermann, R. “Monoclonal antibodies,”Human Cell1(1): 46-53, 1988 (Abstract Only; PubMed ID:3154013).
Arceci, R.J, “The potential for antitumor vaccination in acute myelogenous leukemia,”J. Mol. Med.76: 80-93, 1998.
Baldi et al., “Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer,”Clinical Cancer Research3(10):1691-1697, Oct. 1997.
Bergers and Coussens, “Extrinsic regulators of epithelial tumor progression: metalloproteinases,”Current Opinion in Genetics & Developments10: 120-127, 200.
Bodey, B. et al., “Failure of Cancer Vaccines: The Significant Limitations of this Approach to Immunotherapy,”Anticancer Research20: 2665-2676, 2000.
Boon, T., “Toward a Genetic Analysis of Tumor Rejection Antigens,”Advances in Cancer Research58: 177-210, 1992.
Brass et al., “Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma,”Human Molecular Genetics, 6(1): 33-39, 1997.
Chen, Shen-Lin et al., “Isolation and characterization of a novel gene expressed in multiple cancers,”Oncogene12: 741-751, 1996.
Chen, Y.-T. et al., “A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening”Proc. Natl. Acad. Sci. USA94: 1914-1918, Mar. 1997.
Database EMBL Nucleotide and Protein Sequence, Accession No. AI468638, Mar. 17, 1999.
Database EMBLest17 Accession No. AA340797:EST46165 Fetal kidney II Homo sapiens cDNA 3' end, Apr. 18, 1997.
Database EMBLest17 Accession No. W22264:Human retina cDNATsp-509I-cleaved sublibrary Homo sapiens cDNA not directional, May 9, 1996.
Davidson et al., “Lung tumours immunoreactive for parathyroid hormone related peptide: analysis of serum calcium levels and tumor type,”Journal of Pathology178:398-401, Jan. 1996.
Ezzell, C., “Cancer ‘Vaccines’: An Idea Whose Time Has Come?”The Journal of NIH Research7: 46-49, Jan. 1995.
Finch et al., “Identification of a cloned sequence activated during multi-stage carcinogenesis in mouse skin,”Carcinogenesis, 12(8):1519-1522, Aug. 1991.
GenBank Database, Accession No. AAB82295, Oct. 30, 1997.
GenBank Database, Accession No. AAB97457, Jan. 22, 1998.
GenBank Database, Accession No. AAC18597, Jun. 3, 1998.
GenBank Database, Accession No. AAC18598, Jun. 3, 1998.
GenBank Database, Accession No. AAC35208, May 13, 1007.
GenBank Database, Accession No. AAC41285, May 13, 1998.
GenBank Database, Accession No. AAD09223, Jan. 26, 1999.
GenBank Database, Accession No. AAD09827, Jan. 26, 1999.
GenBank Database, Accession No. AAD09828, Jan. 26, 1999.
GenBank Database, Accession No. AAD48397, Aug. 11, 1999.
GenBank Database, Accession No. AAF37203, Mar. 2, 2000.
GenBAnk Database, Accession No. AB026833, May 26, 1999.
GenBAnk Database, Accession No. AC005082, Sep. 8, 1999.
GenBank Database, Accession No. AC021876, Jan. 21, 2000.
GenBank Database, Accession No. AC079780, Feb. 21, 2002.
GenBank Database, Accession No. AC092447, Jul. 4, 2001.
GenBank Database, Accession No. AF043977, Jun. 23, 1999.
GenBank Database, Accession No. AF114429, Jan. 1, 2000.
GenBank Database, Accession No. AF117108, Jan. 26, 1999.
GenBank Database, Accession No. AF127980, Aug. 11, 1999.
GenBank Database, Accession No. AF198254, Mar. 2, 2000.
GenBank Database, Accession No. AL023775, Nov. 23, 1999.
GenBank Database, Accession No. BAA77810, May 26, 1999.
GenBank Database, Accession No. BAB19755, Dec. 20, 2000.
GenBank Database, Accession No. BAB27779, Feb. 8, 2001.
GenBank Database, Accession No. BAB27848, Feb. 8, 2001.
GenBAnk Database, Accession No. BC019258, Dec. 19, 2001.
GenBank Database, Accession No. NM—006536, Aug. 10, 1999.
GenBank Database, Accession No. NM—006547, Nov. 1, 2000.
GenBank Database, Accession No. NM—006527, Aug. 10, 1999.
GenBAnk Database, Accession No. NP—006537, Aug. 10, 1999.
GenBank Database, Accession No. NP—006538, Nov. 1, 2000.
GenBank Database, Accession No. NP—006539, Aug. 10, 1999.
GenBank Database, Accession No. NP—034081, Jan. 25, 2000.
GenBank Database, Accession No. NP—076159, Feb. 19, 2001.
GenBank Database, Accession No. NP—571566, Feb. 20, 2002.
GenBank Database, Accession No. O00425, Jul. 1, 1997.
GenBank Database, Accession No. U76705, Jan. 26, 1999.
GenBank Database, Accession No. U85946, Jul. 30, 1999.
GenBank Database, Accession No. U97188, May 20, 1997.
GenBAnk Database, Accession No. XM—004780, Nov. 16, 2000.
GenBank Database, Accession No. XP—004780, Nov. 16, 2000.
Geneseq Accession No. AAC66035, Feb. 21, 2001.
Geneseq Accession No. AAZ24653, Dec. 7, 1999.
Geneseq Accession No. AAZ36150, Dec. 7, 1999.
Geneseq Database (Thomson Derwent), Accession AAL28189, Jan. 24, 2002.
Geneseq Database (Thomson Derwent), Accession AAM93826, Nov. 6, 2001.
Geneseq Database (Thomson Derwent), Accession AAT26750, Oct. 23, 1996.
Geneseq Database (Thomson Derwent), Accession AAU16161, Nov. 7, 2001.
Geneseq Database (Thomson Derwent), Accession AAU16163, Nov. 7, 2001.
Geneseq Database (Thomson Derwent), Accession AAU16164, Nov. 7, 2001.
Geneseq Database (Thomson Derwent), Acce
Fanger Gary R
Peckham David W
Retter Marc W
Wang Tongtong
Chen Shin-Lin
Corixa Corporation
Seed IP Law Group PLLC
LandOfFree
Compositions and methods for the therapy and diagnosis of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the therapy and diagnosis of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the therapy and diagnosis of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3836583